Histone deacetylase 2 is involved in �‑opioid receptor suppression in the spinal dorsal horn in a rat model of chronic pancreatitis pain
Authors:
Open Access
- 11 December 2017
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 17 (2) , 2803-2810
Abstract
Chronic pain occurs in ~85-90% of chronic pancreatitis (CP) patients. However, as the pathogenesis of CP pain remains to be fully understood, the current therapies for CP pain remain inadequate. Emerging evidence has suggested that the epigenetic modulations of genes are involved in chronic pain. In the present study, intrapancreatic trinitrobenzene sulfonic acid infusions were used to establish a CP model in rats. Mechanical allodynia was measured with von Frey filaments. Immunofluorescent staining analysis was used to observe the expression changes of histone deacetylase 2 (HDAC2) and µ‑opioid receptor (MOR), and intrathecal administration of the selective HDAC2 inhibitor AR‑42 was used to assess the underlying mechanisms. The expression levels of c‑Jun N‑terminal kinase (JNK) in the thoracic spinal cord were detected by western blotting, and the mRNA expression levels of interleukin (IL)1‑β, IL‑6 and tumor necrosis factor (TNF)‑α were detected by reverse transcription‑quantitative polymerase chain reaction. The results demonstrated that HDAC2 expression was upregulated during the course of CP induction, while MOR activity in the thoracic spinal dorsal horn was significantly suppressed. Intrathecal infusion of AR‑42 significantly attenuated CP‑induced mechanical allodynia, with rescued MOR activity. Additionally, HDAC2 facilitated the release of inflammatory cytokines, including IL‑1β, IL‑6 and TNF‑α. These results suggested that the underlying mechanisms of HDAC2 regulating MOR activity under CP induction may occur via promoting the release of inflammatory cytokines, thus activating the JNK signaling pathway. The present study suggested that the epigenetic‑regulated disturbance of MOR is dependent on the endogenous analgesia system in CP, which may a provide novel therapeutic strategy for treating pain in CP.Keywords
This publication has 40 references indexed in Scilit:
- The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γJournal of Neuroinflammation, 2012
- Epigenetic suppression of GAD65 expression mediates persistent painNature Medicine, 2011
- Probing the role of HDACs and mechanisms of chromatin-mediated neuroplasticityNeurobiology of Learning and Memory, 2011
- p38 Mitogen‐activated protein kinase and PI3‐kinase are involved in up‐regulation of mu opioid receptor transcription induced by cycloheximideJournal of Neurochemistry, 2010
- Up-Regulation of the μ-Opioid Receptor Gene Is Mediated through Chromatin Remodeling and Transcriptional Factors in Differentiated Neuronal CellsMolecular Pharmacology, 2010
- HDAC inhibitors and neurodegeneration: At the edge between protection and damagePharmacological Research, 2010
- Histone Deacetylase Inhibitors Suppress the Expression of Inflammatory and Innate Immune Response Genes in Human Microglia and AstrocytesJournal of Neuroimmune Pharmacology, 2010
- Inhibition of Class II Histone Deacetylases in the Spinal Cord Attenuates Inflammatory HyperalgesiaMolecular Pain, 2010
- HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in ratsBrain Research, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001